Median Nerve Flossing Technique in Patients With Cervical Radiculopathy
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 3, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called the median nerve flossing technique for people with cervical radiculopathy, a condition where nerves in the neck are irritated or compressed, causing pain, numbness, or weakness in the arm. The goal of the study is to see if this nerve flossing—gentle movements that help ease tension on the nerve—can reduce pain, improve neck movement, and help with daily activities.
The study is looking for men and women between the ages of 30 and 50 who have had neck and arm symptoms for more than three months and show positive results on specific physical tests that indicate nerve irritation. If you join the trial, you can expect to try the nerve flossing technique to see how it affects your symptoms. People with certain other health problems, like severe arthritis or lung disease, or those whose pain comes from the shoulder rather than the neck, would not be eligible. This study has not started recruiting participants yet.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria:• Both male and female gender were included
- • Participants with 30 to 50 years of age group were taken in this study (Gore et al., 2020)
- • Patients with positive Spurling test ,cervical distraction ,cervical rotation test were included
- • Participants with positive Upper limb neural tension test for median nerve were taken into consideration
- • Patients who are having radicular symptoms and pain for more than 3 months were included
- Exclusion Criteria:
- • Systematic disorders affecting musculoskeletal disorders e.g. Ankylosing spondylitis,rheumatic arthritis etc.
- • Patient with primary shoulder or upper limb pain origin
- • Patients with severe malignancy,COPD ,isch
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Asif Sheikh, MBBS FCPS
Study Chair
Pediatric clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported